Cases 31 - 40 of 53
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01495
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas US LLC et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01160
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Dr. Reddy's Laboratories, Inc. et al.
as 1:2019cv00750
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Genzyme Corp. et al v. Dr. Reddys Laboratories, Inc. et al
as 1:2018cv01839
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Plaintiff:
The Regents of the University of Michigan and Genzyme Corp.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2018cv01779
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. v. Dr. Reddys Laboratories, Ltd. et al
as 1:2018cv00101
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Dr. Reddys Laboratories, Inc et al.
as 1:2017cv01811
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
